TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6285445

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg, 3 times daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg, 3 times daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30845731

Group type: EXPERIMENTAL
Intervention: Combined supplementation with glycine (3.0 g) and tryptophan (0.2 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 0
Study: 29069016

Group type: EXPERIMENTAL
Intervention: Cryotip application (-10°C for 15 seconds)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no cryotip application)
Number of subjects: 30
Study: 27266506

Group type: EXPERIMENTAL
Intervention: Auricular point acupressure (APP) treatment using vaccaria seeds on the large intestine point (CO7)
Number of subjects: 0

Group type: COMPARATOR
Intervention: APP sham stimulation
Number of subjects: 0
Study: 24864635

Group type: EXPERIMENTAL
Intervention: Tubularised incised plate urethroplasty
Number of subjects: 60

Group type: COMPARATOR
Intervention: Onlay island flap repair
Number of subjects: 60
Study: 21883559

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with polyethylene glycol
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide paste with chlorhexidine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Biomechanical preparation
Number of subjects: 32
Study: 18992952

Group type: EXPERIMENTAL
Intervention: RT+CON (radiotherapy with carbogen and nicotinamide)
Number of subjects: 165

Group type: COMPARATOR
Intervention: RT (radiotherapy alone)
Number of subjects: 165
Study: 17592648

Group type: EXPERIMENTAL
Intervention: Traditional Food group (TFG)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Meal Replacement Group (MRG)
Number of subjects: 96
Study: 15279340

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (Group E)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Spinal anesthesia (Group S)
Number of subjects: 114
Study: 12503840

Group type: EXPERIMENTAL
Intervention: Ethanol (0.7 g/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9802364

Group type: EXPERIMENTAL
Intervention: Fel d 1 peptides (high dose, 750 micro(g))
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fel d 1 peptides (medium dose, 75 micro(g))
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Fel d 1 peptides (low dose, 7.5 micro(g))
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 7636411

Group type: EXPERIMENTAL
Intervention: Method 2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Method 1
Number of subjects: 60
Study: 2367154

Group type: EXPERIMENTAL
Intervention: Williamson‐Kligmann technique (on the epidermis of the forearm)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bag of Gaschen technique (on the hands)
Number of subjects: 10
Study: 138573

Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 0
Study: 30694609

Group type: EXPERIMENTAL
Intervention: Oral care with sterile normal saline
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study: 28617377

Group type: EXPERIMENTAL
Intervention: Laennec infusions (10 intravenous infusions, 4 ml each, 2 times/week for 5 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 38
Study: 26491117

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (9 mg elemental zinc daily for 4 weeks)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo (identical tablet for 4 weeks)
Number of subjects: 147
Study: 24036613

Group type: EXPERIMENTAL
Intervention: Intraoperative periarticular infiltration with ropivacaine, clonidine, morphine, epinephrine and corticosteroids
Number of subjects: 63

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with morphine
Number of subjects: 63

Group type: COMPARATOR
Intervention: Continuous epidural infusion with ropivacaine
Number of subjects: 63
Study: 21763247

Group type: EXPERIMENTAL
Intervention: Standard endotracheal intubation (ETI)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Supraglottic airway device (King LTS‐D)
Number of subjects: 204
Study: 18952450

Group type: EXPERIMENTAL
Intervention: Left atrial plus cavotricuspid isthmus ablation (left atrial group)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Biatrial ablation (biatrial group)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Overall patients
Number of subjects: 299
Study: 16530831

Group type: EXPERIMENTAL
Intervention: varR1-CHOP (1 cycle of rituximab + 6 cycles of CHOP)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: varR3-CHOP (3 cycles of rituximab + 6 cycles of CHOP)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: varR6-CHOP (6 cycles of rituximab + 6 cycles of CHOP)
Number of subjects: 16
Study: 15312558

Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg, twice daily for 5 days)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control (symptom relief medicine only)
Number of subjects: 108
Study: 11224816

Group type: EXPERIMENTAL
Intervention: BSA only (SA25)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combination of BSA and resistance exercise (SAR)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: BSA only (SA40)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 35
Study: 9085965

Group type: EXPERIMENTAL
Intervention: Acupressure at the P.6 (Nei‐Guan) point
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group with inappropriate placement of acupressure bands
Number of subjects: 200
Study: 8338516

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 17032

Group type: EXPERIMENTAL
Intervention: Intrauterine devices
Number of subjects: 17032

Group type: COMPARATOR
Intervention: Diaphragm
Number of subjects: 17032
Study: 3464622

Group type: EXPERIMENTAL
Intervention: Customized regimen based on DDFM (T group)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 3-month recalls (C group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: DDFM of subgingival bacterial morphotypes
Number of subjects: 90
Study: 31220326

Group type: EXPERIMENTAL
Intervention: Low-intensity, multicomponent childhood overweight/obesity intervention
Number of subjects: 963

Group type: COMPARATOR
Intervention: Families informed about the program
Number of subjects: 963
Study: 30550321

Group type: EXPERIMENTAL
Intervention: Monitor + Accept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitor Only
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 0
Study: 27353149

Group type: EXPERIMENTAL
Intervention: Bimonthly, discount, mobile fresh fruit and vegetable markets combined with a nutrition education intervention (two F&V campaigns, newsletters, DVDs, and cooking demonstrations) for 12 months.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Physical activity and stress reduction interventions (Control group).
Number of subjects: 15
Study: 24926950

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 11.25 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 30 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot (both doses)
Number of subjects: 72
Study: 22897185

Group type: EXPERIMENTAL
Intervention: Peer‐CDSMP (Cardiac‐Diabetes Self‐Management Program)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 20631016

Group type: EXPERIMENTAL
Intervention: Good glycemic control (HbA(1c) <6.5%)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Poor glycemic control (HbA(1c) >6.5%)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Decrease in insulin sensitivity (1 mg x kg(‐1) x min(‐1))
Number of subjects: 273
Study: 18768000

Group type: COMPARATOR
Intervention: Halogen lamp (550 mW/cm² for 20 seconds)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LED (550 mW/cm² for 25 seconds)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 16% carbamide peroxide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no bleaching)
Number of subjects: 24
Study: 16006212

Group type: EXPERIMENTAL
Intervention: Peer education (n = 204)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Single-session lecture (n = 74)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Wait-list control (n = 109)
Number of subjects: 204
Study: 12235693

Group type: EXPERIMENTAL
Intervention: Antibiotic therapy for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9952142

Group type: EXPERIMENTAL
Intervention: Endotracheal tube
Number of subjects: 52

Group type: COMPARATOR
Intervention: Laryngeal mask airway
Number of subjects: 52
Study: 7591530

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation for one year
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 2180105

Group type: EXPERIMENTAL
Intervention: Oral prednisolone 40 mg per day for two weeks
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone dipropionate 500 micrograms thrice daily for two weeks
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 6110436

Group type: EXPERIMENTAL
Intervention: Isoprenaline 10 or 20 mg sublingually 30 min before the meal
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Salbutamol 4 mg four times daily for 1 week
Number of subjects: 24

Group type: COMPARATOR
Intervention: Propranolol 40 mg four times daily for 1 week (after isoprenaline)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg four times daily for 1 week (alone)
Number of subjects: 24
Study: 6401954

Group type: EXPERIMENTAL
Intervention: Oral sodium cromoglycate, 1600 mg daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30734679

Group type: EXPERIMENTAL
Intervention: Serum MTHFR levels (first quintile)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Serum MTHFR levels (second quintile)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Serum MTHFR levels (fourth quintile)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Serum MTHFR levels (fifth quintile)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: MTHFR quintiles added to a model with conventional risk factors
Number of subjects: 395
Study: 29541927

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy (PE)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Treatment choice (choice vs no-choice)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Treatment preference (preferred vs non-preferred)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pharmacotherapy with sertraline (SER)
Number of subjects: 200
Study: 26514581

Group type: EXPERIMENTAL
Intervention: 20 mg oral THC
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 24582372

Group type: EXPERIMENTAL
Intervention: Combined transcranial direct current stimulation (tDCS) and peripheral electrical stimulation (PES)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS) alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Peripheral electrical stimulation (PES) alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 16
Study: 22841969

Group type: EXPERIMENTAL
Intervention: Lidocaine patch 5%
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 20352261

Group type: EXPERIMENTAL
Intervention: 2-octylcyanoacrylate (2-OCA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Skin staples
Number of subjects: 74
Study: 18046054

Group type: EXPERIMENTAL
Intervention: CHO gel
Number of subjects: 7

Group type: COMPARATOR
Intervention: PLA
Number of subjects: 7
Study: 16082279

Group type: EXPERIMENTAL
Intervention: OAC-LC (omeprazole, amoxicillin, clarithromycin for 7 days supplemented with fermented milk containing L. casei DN-114 001 for 14 days)
Number of subjects: 86

Group type: COMPARATOR
Intervention: OAC (omeprazole, amoxicillin, and clarithromycin for 7 days)
Number of subjects: 86
Study: 12171816

Group type: EXPERIMENTAL
Intervention: O2‐C (conventional oxygen cylinder)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: O2‐HF (refilled oxygen cylinders)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: O2‐HFs
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: O2‐C and O2‐HF
Number of subjects: 10
Study: 10211146

Group type: EXPERIMENTAL
Intervention: Olanzapine (5‐20 mg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Haloperidol (5‐20 mg)
Number of subjects: 300
Study: 7796655

Group type: EXPERIMENTAL
Intervention: Diet intervention
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Diet plus exercise intervention
Number of subjects: 577

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 577
Study: 2196085

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA) at 2.5 mg/kg/day
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA) at 5 mg/kg/day
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 563

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 563

Group type: COMPARATOR
Intervention: Etretinate
Number of subjects: 563
Study: 314234

Group type: EXPERIMENTAL
Intervention: Surgical therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 51
Study: 31884318

Group type: EXPERIMENTAL
Intervention: Mindfulness-based focused attention training (MBAT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Progressive muscle relaxation training (PMR)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups (MBAT and PMR)
Number of subjects: 78
Study: 31155138

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 28770893

Group type: EXPERIMENTAL
Intervention: Activity Repetition Training with Salat (prayer)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Task Oriented Training
Number of subjects: 32
Study: 27421262

Group type: EXPERIMENTAL
Intervention: Hospital-based home care (HBHC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hospital-based care
Number of subjects: 60
Study: 25394949

Group type: EXPERIMENTAL
Intervention: Prehabilitation program (individualized exercise program including pelvic floor muscle strengthening instructions and a healthy lifestyle guide)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (same pelvic floor muscle strengthening instructions and healthy lifestyle guide only)
Number of subjects: 100
Study: 22569488

Group type: EXPERIMENTAL
Intervention: Spinal Manipulation (SM)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Back School (BS)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Individual Physiotherapy (IP)
Number of subjects: 210
Study: 19337010

Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp30) + metformin (met)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Premixed human insulin 30/70 (BHI30) + metformin (met)
Number of subjects: 50
Study: 17261662

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d
Number of subjects: 10001

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d (in patients with a history of HF)
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d (in patients with a history of HF)
Number of subjects: 10001

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d (in patients without a history of HF)
Number of subjects: 10001

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d (in patients without a history of HF)
Number of subjects: 10001
Study: 15289727

Group type: EXPERIMENTAL
Intervention: Low-dose daily chemotherapy (50 mg carboplatin and 50 mg etoposide)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Daily chemotherapy (30 mg carboplatin and 30 mg etoposide) with weekend chemotherapy (100 mg of each on Saturdays and Sundays)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: High-dose hyperfractionated radiation therapy (69.6 Gy) with concurrent chemotherapy
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Weekend chemotherapy group
Number of subjects: 301
Study: 11318298

Group type: EXPERIMENTAL
Intervention: Pilocarpine 2% eye drops
Number of subjects: 16

Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 16
Study: 9815660

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 8306241

Group type: EXPERIMENTAL
Intervention: I.M. clonazepam (1 to 2 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: I.M. haloperidol (5 to 10 mg)
Number of subjects: 16
Study: 3102056

Group type: EXPERIMENTAL
Intervention: melphalan (8 mg/m2 orally for 4 days)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: melphalan (6 mg/m2 for 4 days) and hexamethylmelamine (120 mg/m2 for 14 days) every 4 weeks
Number of subjects: 205
Study: 31077799

Group type: EXPERIMENTAL
Intervention: Intermittent cycling exercise (12 min, 15 s work - 15 s rest)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive recovery
Number of subjects: 10
Study: 28068789

Group type: EXPERIMENTAL
Intervention: Advance Care Planning Video Program
Number of subjects: 360

Group type: COMPARATOR
Intervention: Usual advance care planning practices
Number of subjects: 360
Study: 24811085

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (630 nm, 28 mW, continuous wave, 60 s, 1.68 J)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo application (laser simulation)
Number of subjects: 31
Study: 23054042

Group type: EXPERIMENTAL
Intervention: Wisebag with online (events transmitted via cellular signal in real-time)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Wisebag with offline (events stored in device memory)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inactive 'dummy' devices
Number of subjects: 50
Study: 21496138

Group type: EXPERIMENTAL
Intervention: IV acetaminophen 1 g
Number of subjects: 105

Group type: COMPARATOR
Intervention: PO acetaminophen 1 g
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 105

Group type: COMPARATOR
Intervention: PO acetaminophen
Number of subjects: 105
Study: 19491687

Group type: EXPERIMENTAL
Intervention: Home-based maintenance exercise with group training sessions every 2 weeks after an initial 8-week training program
Number of subjects: 66

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Home-based maintenance exercise
Number of subjects: 66
Study: 16316746

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALCAR) 500 mg b.i.d.
Number of subjects: 204

Group type: COMPARATOR
Intervention: Amisulpride 50 mg u.i.d.
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALCAR)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALCAR) and Amisulpride
Number of subjects: 204
Study: 15059192

Group type: EXPERIMENTAL
Intervention: Fermented milk with Lactobacillus paracasei‐33 (LP‐33), 2 x 10(9) colony‐forming units per bottle for 30 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (fermented milk without LP‐33)
Number of subjects: 80
Study: 10848901

Group type: EXPERIMENTAL
Intervention: Intranasal mometasone furoate 200 microgram
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Oral montelukast 10 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 8798046

Group type: EXPERIMENTAL
Intervention: Iopentol (Imagopaque); 300 mg I/ml, injected at 2 ml/kg b.w. (max 100 ml)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Ioxaglate (Hexabrix); 320 mg I/ml, injected at 2 ml/kg b.w. (max 100 ml)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Overall quality of CT enhancement
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Adverse events, blood pressure, heart rate changes
Number of subjects: 89
Study: 1595851

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 40
Study: 6748661

Group type: EXPERIMENTAL
Intervention: 250 mg/day of disulfiram
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 500 mg/day of disulfiram
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30944040

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 29028981

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID for 8 weeks
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID for 52 weeks
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID for 52 weeks
Number of subjects: 593

Group type: COMPARATOR
Intervention: Placebo for 52 weeks
Number of subjects: 593
Study: 26895021

Group type: EXPERIMENTAL
Intervention: PF-05089771
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PF-05150122
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PF-05186462
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PF-05241328
Number of subjects: 0
Study: 25273653

Group type: EXPERIMENTAL
Intervention: 3S anastomosis group (80 cases, 3S jejunal interposition)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Traditional anastomosis group (73 cases, esophageal remnant gastric posterior wall anastomosis)
Number of subjects: 153
Study: 22917452

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent (ZES)
Number of subjects: 2332

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 2332
Study: 20401662

Group type: EXPERIMENTAL
Intervention: B vitamins alone (1 mg folic acid, 7.2 mg pyridoxine, 0.02 mg cyanocobalamin daily)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Antioxidants alone (150 mg ascorbic acid, 67 mg vitamin E, 9 mg β-carotene daily)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: B vitamins with antioxidant vitamins
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 18556882

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 0